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Background: Fermented milks containing probiotic bacteria are a way of delivering bioactive
constituents to targets in the gastrointestinal tract. We reported previously that the fermentation
of milk at constant pH 6 by L. helveticus R389 increased its content of peptide fractions, and the oral
administration of the non-bacterial fraction (FMSpH6) to mice increased total secretory IgA in the
intestinal lumen and enhanced the number of IgA and various cytokines producing cells as well as
the secretion of IL-6 by small intestine epithelial cells. We also demonstrated that this FMSpH6 was
effective for the prevention of Salmonella typhimurium infection in mice. In this work, we studied in
mice the impact of the oral administration of the supernatant of milk fermented by L. helveticus R389
on the gut physiology by measuring parameters such as calcium channels and E-cadherin
expression, the activation of the biological signal calcineurin and mast and goblet cells, as a way to
determine some mechanisms involved in the immunomodulating effects of the milk fermentation
products, observed in previous studies. We analyzed the impact of the supernatant of milk
fermented by L. helveticus R389 at pH6-controlled on the expression of calcineurin and on the
reinforcement of the ephitelial barrier, measuring parameters such as calcium channels and E-
cadherin expression and in the reinforcement of the non-specific immunity determining mast cells
and goblet cells associated to the gut.
Results: We observed an enhanced expression of TRPV6 channels in the duodenum, indicating an
improved capacity for dietary Ca2+ uptake. We demonstrated an enhanced expression of
calcineurin in the small intestine, able to upregulate immune parameters such as IL-2 and TNF
production, with an increase in the number of these cytokines secreting cells. We determined an
increase in the number of mucosal mast cells and goblet cells, which would mean an improved state
of mucosal surveillance at sites of infection.
Conclusion: The oral administration of the supernatant of milk fermented by L. helveticus R389
enhanced the gut mucosal immunity by improving the mechanisms that reinforce the epithelial and
non-specific barriers and the gut functioning at sites of infection, with an improvement in the
expression of the enzyme calcineurin, an important signal in the network that activates the gut
immune system. The results of this work contribute to revealing the mechanisms underlying the
immunomodulation of the gut immune function by fermented milks with probiotic bacteria.
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Background
Fermented milks with probiotic microorganisms are a way
of delivering active constituents to targets in the gastroin-
testinal tract. Advances in probiotic development include
the knowledge of the active constituents responsible for
each effect, of the target sites and of the pharmacokinetics
of probiotics. Most pharmacokinetic studies have
described the fate of probiotics (i.e. usually their 'sur-
vival') in the gastrointestinal tract. In fact, the active con-
stituents are seldom known, and their pharmacokinetics,
except for those of lactase from yogurt bacteria, cannot
therefore be assessed [1].
Milk is recognized as a nutritional source of high quality
proteins. Although milk proteins have long been consid-
ered an important source of amino acids, milk proteins
have also the potential to produce biologically active pep-
tides. Various bioactive peptides have been isolated from
hydrolysates of casein, which including opioid agonists or
antagonists, angiotensin-converting enzyme inhibitors,
and immunostimulating peptides [2,3]. Peptides derived
from milk fermentation appear to survive gastrointestinal
digestion and have been recovered from faeces; therefore,
it seems probable that the peptides generated by the bac-
teria found in yogurt or other fermented milks affect gut
and immune cells directly [3]. Additionally, compounds
other than peptides may also be produced by bacterial fer-
mentation [4]. Among lactic acid bacteria, Lactobacillus
helveticus is known to possess elevated amounts of prote-
olytic activity [5,6], which maximizes the probabilities of
releasing bioactive peptide [7]. Laffineur et al. [8] reported
that supernatants of milk fermented by L. helveticus were
able to modulate the in vitro proliferation of lymphocytes
by acting on cytokine production. Matar et al. [9], using
the proteolytic strain L. helveticus R389, demonstrated that
the bioactive compounds released during milk fermenta-
tion possessed inmunoenhancing and antimutagenic
properties not present in the non-proteolytic mutant. LeB-
lanc et al. [10] demonstrated that the peptide fractions
released from milk proteins by the same strain were able
to induce antitumour activity. Additionally, the protective
humoral immune response after an Escherichia coli
O157:H7 infection in mice was also demonstrated for
these peptidic fractions [11]. Working with non-bacterial
fractions of the fermented milk kefir, we demonstrated
that the cell-free extracts were able to induce the in vivo
production of cytokines by peritoneal macrophages and
adherent cells isolated from Peyer's patches [12] and the
proliferation of IgA- and cytokine-producing cells in the
gut mucosa [13]. In a previous work [14] we reported that
the fermentation of pH 6-controlled milk by L. helveticus
R389 maximized the content of peptide fractions in the
product. We also demonstrated that the non-bacterial
fraction of this fermented milk was able to induce the pro-
liferation of IgA+ B cells, and the increase in the number
of IL-2+, IL-6+, IL-10+, TNFα+ and IFNγ+ producing cells,
the secretion of IL-6 by small intestine epithelial cells and
the luminal content of natural secretory IgA (S-IgA), with-
out synthesis of antibodies directed against this fraction.
We also determined the effectiveness of this non-bacterial
fraction in the prevention against S. typhimurim infection
[15]. In this work, we aimed at further characterizing a
biological signal involved in the immunomodulating
effects observed for this non-bacterial fraction, obtained
from milk fermented by L. helveticus R 389. We analyzed
whether this soluble fraction increased the expression of
the enzyme calcineurin involved in the regulation of IL2
and TNFα cytokines production. Calcineurin is a Ca++-
dependant enzyme able to regulate the production of IL-2
and TNFα [16]. Its expression would play a key role in ini-
tiating the innate immune response due to the capacity of
the cytokine TNFα of initiating the cross-talk among
immune cells [17]. The activation of calcineurin is also
involved in key aspects of the adaptive immune response
since calcineurin mediates IL-2 production, which links
the innate and adaptive responses [18]. Thus we studied
the impact of this supernatant on gut physiology using
parameters such as the expression of calcium channels
and E-cadherin and the effect of this fermented milk
supernatant on mast cells and goblet cells associated with
the gut, which are able to produce substances involved in
intestinal pathogens clearance or mucus, respectively,
both important to reinforce the non-specific intestinal
barrier.
Methods
Animals and bacterial strains
Six-to-eight week-old BALB/c mice weighing from 20 to
25 g were obtained from the random bred colony kept by
our department at CERELA. Each experimental group con-
sisted of 5 mice housed in metallic cages kept in a control-
led atmosphere (temperature 22 ± 2°C; humidity 55 ±
2%) with a 12 h light/dark cycle. Protocols involving the
use of animals were approved by the Animals Protection
Committee of the Research Centre CERELA.
The strain Lactobacillus helveticus R389, isolated from Swiss
cheese, was used for this study. Overnight cultures (16 h,
37°C, aerobic conditions) were obtained in 12% skim
milk (Difco, Becton Dickson and Company, Sparks, MD,
USA) or in MRS broth (Britania, Buenos Aires, Argentina).
Production of fermented milks (without pH control and pH 
6-controlled) and their non-bacterial fractions
Two types of fermented milks were produced with L. hel-
veticus R389: a) a fermented milk (without pH control)
obtained by the inoculation (2%) (approximately 106
CFU/ml) of L. helveticus R389 in 12% skim milk and over-
night incubation (16 h 37°C aerobiosis) and b) at pH 6-
controlled fermented milk. To obtain the latter, 12% (w/BMC Immunology 2007, 8:19 http://www.biomedcentral.com/1471-2172/8/19
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v) skim milk (1 l) was inoculated (2%) (approximately
106 CFU/ml) with an overnight culture (16 h) of L. helve-
ticus R389 and it was fermented using a Bioflo Model 70
13 70 biofermentor (New Brunswick Scientific) at 37°C
with an agitation rate of 100 rpm and CO2 spurging (10
lb/in2; 0.2 l/min). The pH was buffered to 6.00 by the
automatic addition of 8 M NaOH as required during the
fermentation.
In order to obtain the non-bacterial fractions of these fer-
mented milks, the milk obtained by overnight fermenta-
tion (16 h, without pH control, final pH 3.7) was
centrifuged (3500 × g, 4°C 15 min, IEC B-22M centrifuge)
and the supernatant was recovered and kept frozen (-
80°C) until use (from now on referred to as fermented
milk supernatant (FMS). For pH 6-controlled fermented
milk, pH was lowered to 3.7 by the addition of 85% DL-
lactic acid syrup (Sigma-Aldrich, St. Louis, MO, USA) and
it was then centrifuged in the same conditions as previ-
ously described. The supernatant was recovered, adjusted
to pH 6 and kept frozen (-80°C) until use (from now on
referred to as FMSpH6). The total protein content of the
non-bacterial fractions was determined by the Bradford
technique (Quick Start Bradford Protein Assay, Bio-Rad
Laboratories, Hercules, CA, USA). We tested only the pro-
tein content in the supernatant of the fermented milk, to
performed the study in similar conditions as in the previ-
ous papers [14,15].
Determination of calcineurin expression after samples 
administration
For the study of calcineurin expression in the lamina pro-
pria of the small intestine, we determined first the time-
course expression of calcineurin only when FMSpH6 was
administered. Groups of mice received by gavage a single
dose of the FMSpH6, containing 100 µg of total protein.
Control animals received phosphate buffered saline (PBS,
pH 7.4) solution instead. At various times (5 min, 15 min,
30 min, 1 h, 2 h or 3 h) after the administration of the
FMSpH6, animals were anesthetized and sacrificed by cer-
vical dislocation. The small intestine was removed for his-
tological preparation following Sainte-Marie's technique
[19]. After determining the optimal time for calcineurin
expression, groups of mice received a single dose (0.2 ml)
of 1) FMSpH6, 2) milk fermented with L. helveticus R389
(108 CFU/ml) (overnight culture (16 h), without pH con-
trol), 3) 100 µl of a suspension of viable cells of L. helveti-
cus  R389 (108  CFU/ml) obtained in MRS broth,
centrifuged (10 min, 4°C 5000 × g) and washed twice
with PBS, or 4) 0,2 ml PBS (control animals). Animals
were anesthetized and sacrificed by cervical dislocation 15
or 30 min (optimal time for calcineurin expression previ-
ously determined) after the administration of each sam-
ple. The small intestine was removed for histological
preparation following Sainte-Marie's technique [19].
Immunofluorescence tests for the study of the expression 
of calcineurin
Histological slices from the small intestine of treated or
control animals were deparaffinized and rehydrated in a
graded ethanol series and then incubated for 30 min in a
1% blocking solution of BSA (Jackson Immuno Research,
West Grove, PA, USA) at room temperature. Histological
slices were then incubated for 16 h at 4°C with mono-
clonal anti-calcineurin (BD Biosciences Pharmingen, San
Diego, CA, USA). The incubation was followed by two
washes with PBS solution and, finally, sections were
treated for 45 min at 37°C with a dilution of a goat anti-
mouse antibody conjugated with FITC (Jackson Immuno
Research). The results were expressed as the number of
calcineurin-expressing cells (positive: fluorescent cell) per
10 fields (magnification 1000×). Data represent the mean
of three histological slices for each animal for each period
assayed.
Immunofluorescence tests for the study of the expression 
of E-cadherin and TRPV6 calcium channel, IL-2+ and TNF+ 
cells, CD4+ and CD8+ T lymphocytes
In order to analyze the biological impact of the increased
expression of calcineurin, we studied the number of IL2
and TNFα cytokine producing cells and the number of
CD4+ and CD8+ T lymphocytes in the lamina propria of
the small intestine. The expression of E-cadherin and
TRPV6 calcium channels was evidenced in the brush bor-
ders of ephitelial cells of the villi and in the duodenum
respectively, in animals that received by gavage a single
daily dose of 0.2 ml (100 µg of protein) of the FMSpH6
for 2, 5 or 7 consecutive days. Control animals received
0.2 ml PBS instead in the same way as the treated mice. All
animals received, simultaneously and ad libitum, a sterile
conventional balanced diet (proteins 230 g/kg, raw fiber
60 g/kg, total minerals 100 g/kg, Ca 13 g/kg, P 8 g/kg,
moisture and vitamins 120 g/kg). Treated and untreated
mice were sacrificed on the same day (2, 5 or 7).
The small intestine was removed on days 2, 5 or 7 for his-
tological preparation following Sainte-Marie's technique
[19]. Duodenum was separated only for 7 days of admin-
istration of FMS pH6 and processed in the same way for
calcium channel determination by immunofluorescence
assay using the TRPV6 antibody (BD Biosciences
Pharmingen, San Diego, CA, USA).
IL-2+ and TNF-α+ cells were studied by an indirect
immunofluorescence method. Histological slices were
deparaffinized and rehydrated in a graded ethanol series
and then incubated for 30 min in a 1% blocking solution
of BSA (Jackson Immuno Research, West Grove, PA, USA)
at room temperature. Histological slices were then incu-
bated for 60 min at 37°C with rabbit anti-mouse IL-2 or
TNF-α (Peprotech, Inc., Rocky Hill, NJ, USA) polyclonalBMC Immunology 2007, 8:19 http://www.biomedcentral.com/1471-2172/8/19
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antibodies diluted 1:100 in PBS containing 0.1% Saponin
(Sigma). The incubation was followed by two washes with
PBS-Saponin solution. Finally, sections were incubated
for 45 min at 37°C with a dilution (1:100) of goat anti-
rabbit antibody conjugated with FITC (Jackson Immuno
Research) in PBS-Saponin. The incubation was followed
by two washes with PBS-Saponin solution. Results were
expressed as the number of positive+ (fluorescent) cells/
10 fields.
The determination of CD4+ and CD8+ T lymphocytes was
performed in the small intestine lamina propria of the
animals given PBS (control) and FMS pH6 for 2, 5 or 7
consecutive days. CD4+ cells were determined using FITC
anti-mouse CD4 (L3/T4) monoclonal antibody and FITC
anti-mouse and for CD8a (Ly2) monoclonal antibody
(Cederlane Laboratories, Ont., Canada) was used. The
results were expressed as the number of X-producing cells
(positive: fluorescent cell) per 10 fields (magnification
1000×). Data represent the mean of three histological
slices for each animal for each feeding period.
For the study of TRPV6 calcium channel expression, histo-
logical slices from duodenum were treated with affinity
purified goat anti-mouse TRPV6 (E-16) polyclonal anti-
body (Santa Cruz Biotechnology, California, USA). As sec-
ondary antibodies, goat anti-rabbit antibody conjugated
with FITC or FITC conjugated affinity pure rabbit anti-
goat antibody (Jackson Immuno Research) were used,
respectively. For the qualitative study of E-cadherin, anti-
pan cadherin developed in rabbit (Sigma Aldrich, St.
Louis, MO, USA). In both assays the presence of immun-
ofluorescence was observed.
Histological examination of the small intestine for mast 
and goblet cells determination
Serial paraffin sections (4 µm) of small intestine from ani-
mals treated for 2, 5 or 7 days with FMSpH6 and from PBS
control animals were stained with haematoxilin-eosin fol-
lowed by light microscopy examination. Mucosal mast
cells were studied by selective staining of granule content
with Alcian Blue/Safranin. Goblet cells stained blue with
this methodology. Briefly, histological slices were depar-
affinized and rehydrated in a graded ethanol series and
then incubated (room temperature) for 150 min in 1%
Alcian Blue 8Gx solution in 3% acetic acid. Histological
slices were then incubated for 6 min in an eosin solution
and for 40 min in 0.5% safranin solution in 0.1 N HCl.
Histological slices were then dehydrated in a series of eth-
anol and finally mounted using Canada balsam synthetic
(Biopack, Buenos Aires, Argentina). The results were
expressed as the number of goblet or mast cells per 10
fields (magnification 1000×). Data represent the mean of
three histological slices for each animal for each feeding
period.
Statistical Analysis
Data were analyzed using the one-way ANOVA procedure
of SPSS software. The differences between means were
detected by the Duncan's Multiple Range Test [20]. Data
were considered significantly different when P < 0.05.
Results
Determination of time course expression of calcineurin 
and the effect of FMSpH6 in the number of cells expressing 
calcineurin
An antibody directed against calcineurin was used to
study the time-course expression of this enzyme in the
intestine following the administration of the fermented
milk supernatant of milk fermented with L. helveticus
R389 at pH 6-controlled (referred to as FMSpH6). Pictures
in Figure 1 show histological slices of villi from the small
Time course of calcineurin expression in the small intestine Figure 1
Time course of calcineurin expression in the small 
intestine. Calcineurin+ cells in the small intestine lamina 
propria of PBS control mice (a) and 15 min after receiving (by 
gavage) the FMSph6 (b). Magnification 400×. Number of cal-
cineurin+ cells in the small intestine lamina propria of mice 
that received the FMSpH6 compared to PBS control animals 
(c). * Significantly different (P < 0.05) from control mice.
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intestine of control (a) and treated mice (b). Within the
first 15 min of the oral administration of the FMSpH6, an
enhanced expression of calcineurin+ cells was observed
(Fig. 1c) that returned to control values one hour later.
The changes in the number of calcineurin+ cells occurred
within the first 30 min of the oral administration of the
FMSpH6.
Figure 2 shows that when mice received the milk fer-
mented with L. helveticus R389 an enhance in the number
of calcineurin+ cells of greater magnitude that when mice
received the FMSpH6 was observed while a pure culture of
L. helveticus R389 failed to enhance calcineurin expres-
sion.
Study of the effect of FMSpH6 on the expression of 
calcium channel and E -cadherin
The immunofluorescence examination for the expression
of the calcium channel TRPV6 in the proximal intestine of
mice showed immunopositive staining for TRPV6 in the
brush-border membranes of the ephitelial duodenum in
comparison with the control (Fig. 3a). Absorptive epithe-
lial cells in the duodenum stained intensely for TRPV6 for
FMSpH6-treated animals (Fig. 3b) whereas crypt cells
were negative. The expression of E-cadherin in the brush-
border membranes of the villi was not modified com-
pared to control animals (pictures not shown).
Histological studies of the small intestine, effect on T cell 
population and IL2 and TNFα cytokine positive cells 
induced by FMSpH6
The histological examination of slices from the small
intestine of mice that received the FMSpH6 for 2, 5 or 7
consecutive days showed a slight lymphocyte infiltration
in the lamina propria compared to PBS control mice. The
presence of edema or mucosal atrophy was not observed
(pictures not shown). When we analyzed cytokine pro-
duction (Fig. 4), we observed that the oral administration
of the FMSpH6 increased the number of IL-2+ or TNFα+
cells for all feeding periods assayed, compared to PBS con-
trol treatment. There was a significant increase in the
number of CD4+ cells when animals received the
FMSpH6 for 7 consecutive days (43 ± 3 cells/10 fields),
compared to control animals (32 ± 4 cells/10 fields),
while there was no effect on the CD8 T lymphocyte popu-
lation compared to the PBS control (26 ± 1 cells/10
fields).
Effect of FMSpH6 on the number of goblet and mast cells
When we analyzed the effect of FMSpH6 administration
on mast (Fig. 5a and 5c) and goblet cells (Fig. 5b and 5d)
in the small intestine lamina propria, we determined a sig-
nificant increase on day 2 (154 ± 12 cells/10 fields for
mast cells and 115 ± 15 cells/10 fields for goblet cells) that
returned to control values (113 ± 19 cells/10 fields for
mast cells and 79 ± 4 cells/10 fields for goblet cells) on
day 7 for both kind of cells studied.
Discussion
L. helveticus has been traditionally used in the manufac-
ture of Swiss-type cheese and in fermented milks. This
species is known to have a high proteolytic activity. Many
nutrients that enter the gastrointestinal tract with the diet
possess multiple effects that go beyond the classic nutri-
tional ones. In particular, bioactive peptides derived from
various animal and plant proteins were reported to have
antioxidative, antimicrobial, antihypertensive and immu-
nomodulatory activity [21,22]. Other bioactive constitu-
ents present in fermented milks, for example, are
glutamine – energy source for the enterocyte and impor-
tant for maintaining the integrity and the function of the
intestinal barrier [23] or lactulose, that derives from the
heat treatment of milk [24] and that has a recognized role
as prebiotic [25]. What benefits for health and nutrition
do they offer as components added to our diets? It is
within this context that we aimed at furthering the knowl-
edge of the mechanisms underlying the immunoenhanc-
ing properties of the non-bacterial fraction of milk
fermented by L. helveticus R389 reported in a previous
work [14].
Intestinal Ca2+ absorption is a crucial control system in
the regulation of Ca2+ homeostasis because it facilitates
the entry of dietary Ca2+ into the extracellular compart-
ment. Ca2+ is absorbed by two different mechanisms, pas-
sive (paracellular) and active (transcellular) transport. The
Ca2+-binding protein calbinding-D9K is responsible for
the intracellular diffusion of Ca2+  in the enterocyte,
whereas calcineurin is not involved in the active transport
Calcineurin expression in the small intestine after different  treatments Figure 2
Calcineurin expression in the small intestine after dif-
ferent treatments. Number of calcineurin+ cells in the 
small intestine lamina propria of control mice and treated 
animals 15 (grey bar) or 30 (black bar) min after receiving the 
FMSpH6, milk fermented by L. helveticus R389, L. helveticus 
R389 (a suspension of viable cells) or PBS (control). * Signifi-
cantly different (P < 0.05) from control mice.
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of Ca2+ across the epithelium [26]. Calcineurin, a serine/
threonine phosphatase under the control of Ca2+/calmod-
ulin, is abundantly expressed in the brain and broadly dis-
tributed in nonneural tissues as well. Among its several
functions in controlling intracellular Ca2+ signalling, cal-
cineurin participates in gene regulation and external sig-
nal-mediated biological responses in many organisms
and cell types. Calcineurin has been shown to regulate
Ca2+ pumps and exchangers to maintain Ca2+ homeostasis
and to regulate adaptation to high salt stress [27]. In rela-
tion to the immune system, signals transmitted by the T
cell receptor (TCR) activate several biochemical pathways,
including one in which calcineurin is involved. The acti-
vation of this enzyme takes place only minutes after the
antigen is recognized [28]. This fact is in agreement with
our observation of an enhanced expression of cal-
cineurin+ cells in the lamina propria of the small intestine
of mice during the first few minutes that followed the
administration of FMSpH6 (Fig. 1). When we compared
the activation of calcineurin by other means (Fig. 2) such
as fermented milk or the bacterium L. helveticus R389
itself, we observed that the fermented milk was also able
to induce calcineurin activation, probably due to its high
calcium content and to the presence of natural immu-
noregulatory peptides [4]. The highest calcineurin activa-
tion was observed with fermented milk, possibly because
of the increased peptide content due to the fermentation
process. An important fact is that the probiotic strain
alone was unable to induce calcineurin expression (Fig.
2).
At the cellular level, transcellular Ca2+ transport proceeds
via a well controlled sequence of molecular events in
which calcium channels are involved. TRPV5 and TRPV6
(originally named ECaC1 and ECaC2) form a distinct
subfamily within the superfamily of transient receptor
potential channels (TRPs). These channels fulfill impor-
tant physiological functions ranging from phototransduc-
tion, olfaction and heat and cold sensation to epithelial
Effect of FMSpH6 administration on IL-2+ andTNFα+  expression Figure 4
Effect of FMSpH6 administration on IL-2+ andTNFα+ 
expression. Effects of the oral administration of 12% skim 
milk or FMSpH6 for 2 (grey bar), 5 (grey bar) or 7 (black bar) 
consecutive days on the number of IL-2+ and TNFα+ cells in 
the small intestine lamina propria of mice compared to PBS 
control animals (control). * Significantly different (P < 0.05) 
from control mice.
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Effect of FMSpH6 administration on TRPV6 calcium channels expression Figure 3
Effect of FMSpH6 administration on TRPV6 calcium channels expression. Effects of the oral administration of the 
FMSpH6 for 7 days on the expression of TRPV6 calcium channels in PBS control (a) and treated animals (b). Magnification 
1000×.
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calcium transport [29]. TRPV5 and TRPV6 are by far the
most Ca2+-selective channels of the TRP superfamily and
constitute the rate-limiting influx step in active Ca2+
(re)absorption that takes place in kidney, proximal intes-
tine (duodenum) and placenta [30]. In mouse, TRPV6 is
more ubiquitously expressed than in human, whereas
TRPV5 expression is mainly restricted to the kidney.
TRPV6 protein expression, in the mouse and human gas-
trointestinal tract, is essentially restricted to the epithelial
cells, and is largely confined to the apical cell surface. In
duodenum, TRPV5 and TRPV6 proteins are present in a
thin layer along the apical membrane of the villous tips.
As this is the major site for Ca2+ absorption, TRPV5/6
expression patterns are in line with the role of these pro-
teins in dietary Ca2+ uptake [31]. In our work, using an
anti-mouse TRPV6 antibody (Fig. 3), we observed immu-
nopositive fluorescent staining for the TRPV6 calcium
channel in the brush-border membranes of duodenal
absorptive epithelial cells in the villi of control animals. In
mice that received the FMSpH6, the expression of TRPV6
was enhanced, leading us to conclude that the soluble fac-
tors present in the FMSpH6 increased the expression of
calcium channels. It was reported that soluble factors such
as Vitamin D, estrogen and dietary Ca2+ positively regulate
the expression of duodenal TRPV6 [31].
Cell adhesion molecules are cell surface glycoproteins
thought to represent important regulators of tissue mor-
phogenesis. Members of the cadherin protein family are
cell adhesion molecules requiring Ca2+ for binding activ-
ity. Originally, four cadherins were described: epithelial
(E-), neural (N-), placental (P-) cadherins and L-CAM
[32]. Although the intestine expresses several members of
the cadherin family, E-cadherin is the predominant cell
adhesion molecule in the intestinal epithelium [33]. In
our study, the expression of E-cadherin (pictures not
shown) in the brush border of villi was not modified after
FMSpH6 administration, which would indicate that the
active components of the FMSpH6 act at different and
specific levels, thus underlying the importance of the
knowledge not only of the active constituents responsible
for each effect but also of the target sites.
In higher animals, calcineurin is known to regulate the
transcription of the T-cell growth factor, interleukin-2.
Dephosphorylation of the transcriptional factor NF-ATp
(nuclear factor-activated T cells) by calcineurin is required
for the translocation of NF-AT from the cytoplasm to the
nucleus in response to an increased intracellular Ca2+ level
[27]. Lamina propria T cells differ from peripherial blood
T cells in the fact that the former are better activated by
CD2 and CD28 stimulation and show a high expression
of IL-2 and IFNγ [34]. We observed that the oral adminis-
tration of FMSpH6 increased the number of IL-2+ and
TNFα+ cells (Fig. 4). Since the calcineurin pathway is part
of intracellular signals at different levels [35], we hypoth-
esized that the calcium content of milk induced the acti-
vation of calcineurin. The enhanced content of peptide
fractions in the FMSpH6 compared to milk efficiently
would have signaled cytokine production by the T cell
population, in agreement with the enhanced number of
CD4+ T lymphocytes induced by FMSpH6. The results
obtained in this work indicate that the immune cells
involved in the adaptative immunity, as the CD4 T popu-
lation, were also activated by the components of the
FMSpH6. However, we cannot rule out the possibility that
calcineurin activation may have simultaneously occurred
in macrophages, since the presence of the Ca2+/calmodu-
lin-dependent protein phosphatase calcineurin was also
reported in macrophages [36]. It was demonstrated that
lamina propria B cells play a significant role in regulating
lamina propria T cells. Additionally, intestinal epithelial
cells can participate in antigen presentation to T cells and
Effect of FMSpH6 administration on mast and goblet cells  expression Figure 5
Effect of FMSpH6 administration on mast and goblet 
cells expression. Mast (a) and goblet (b) cells in the small 
intestine lamina propria of PBS control mice. Mast (c) and 
goblet (d) cells in animals that received FMSph6 for 2 consec-
utive days. Magnification 1000×.
1
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(c)       (d)  4
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7
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the cytokines secreted by the former have direct effects on
the latter [34]. In this sense, in a previous paper (14) we
demonstrated that FMSpH6 did not induce S-IgA specific,
thus we believe that, the activation of T cells by FMSpH6
observed in the lamina propria could follow a pathway of
activation, up to day unknown for us, which differ from
the classical ones through the TCR for peripherial blood T
cells.
Mast cells cross the dividing line between innate and
acquired immune responses because of the presence of
membrane-bound, polyclonal, antigen-specific IgE,
which mediates degranulation via antigen recognition
[37]. Over the past few years a great deal has been learned
about the potential of mast cells as effector cells in a wide
range of immune and inflammatory responses. These cells
have an important role in allergic responses through IgE-
mediated cell activation. However, the non-IgE-mediated
activation pathways of mast cells, which may induce the
production of selected mediators, including cytokines
[38], are probably of more relevance to both host defense
and chronic inflammatory disorders. In our work, an
increase in the number of mast cells in the lamina propria
was observed after FMSpH6 administration (Fig. 5c). It
was reported that, in certain cases, mast cells produced
cytokines in response to a stimulus that did not induce
degranulation [38]. There is growing evidence that mast
cells recognize and react, often in a beneficial manner, to
a wide range of microorganisms and their products [39],
favouring their clearance, which could also be our case.
Edwards et al. [40] reported that diets containing different
protein sources were able to increase the number of
colonic mast cells. The return of the number of mast cells
to control values on day 7 could be due to the increase in
the number of IL-10 cells, as reported in a previous work
[14] since IL-10 is a very potent inhibitor of mast cells,
probably because of the need to maintain intestinal
homeostasis. Goblet cells, present in both the small and
large intestine, release mucus granules from the apical
cytoplasm after an inflammatory stimulus. Mucus secre-
tion is triggered by both direct stimulation by immune
complexes and chemical agents and indirect stimulation
by mediators released by histamine and lymphokines
[41]. However, mucus secretion is also stimulated by
other factors such as neurogenic factors and resident
microflora [42]. In a previous work in our laboratory,
Gauffin Cano et al. [43] reported the increase in the
number of goblet cells after the administration of the pro-
biotic strain L. casei CRL 431 in a malnourished mouse
model. Goblet cells could be considered as a possible
indication of an increased non-specific barrier or an
increase of the innate response. In our model of healthy
animals, the proliferation of goblet cells (Fig. 5d) cannot
be related to an inflammatory process, as indicated by the
results obtained with the haematoxilin-eosin study (pic-
tures not shown). Breves et al. [44] reported that the oral
administration of oligosaccharides modified the func-
tional parameters of the intestinal tract of pigs, increasing
the number of ileal goblet cells.
In conclusion, in the present work, we demonstrated the
significant contribution of the oral administration of the
fermented milk supernatant from milk fermented by L.
helveticus R389 for the improvement of the immune and
physiological parameters of the gut. The enhanced expres-
sion of TRPV6 channels in the duodenum indicates an
improved capacity for dietary Ca2+ uptake. An enhanced
expression of calcineurin able to activate the transcrip-
tional factor NFAT to regulate IL-2 and TNFα production
and the increase in local mast and goblet cells would
point to an improved state of mucosal surveillance at sites
of infection. The oral administration of FMSpH6 tran-
siently affected the gut mucosal immunity and gut func-
tioning. The induction of transient effects would assure
temporal effects that would not persist longer than the
feeding period. The transient activation of calcineurin and
calcium transporters by the FMSpH6 would enhance gut
mucosal innate immunity and calcium availability, rein-
forcing the innate defence mechanisms and the nutri-
tional status of the host. The enhanced presence of goblet
cells would insure an improved synthesis of mucus, which
has important immune and non-immune functions that
would help to protect the epithelial surface. All these
events improve the intestinal barrier and functioning,
increasing host protection against infections, as we
recently demonstrated [15].
Conclusion
The oral administration of the FMS from fermented milks
may positively affect the milieu of the intestinal lumen.
We demonstrated that soluble dietary constituents
present in the lumen can influence the functions of the
intestine and increasing immunological parameters with-
out altering intestinal homeostasis, thereby enhancing the
health condition of the host.
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